Drug Detail

Drug Name Cetuximab
Trade Name Erbitux
Synonyms
Drug Descriptions

Erbitux (cetuximab) is a monoclonal antibody directed against EGFR, which inhibits signal transduction and cell proliferation (PMID: 28695301). Erbitux (cetuximab) is FDA approved for use in head and neck squamous cell carcinoma and KRAS wild-type, EGFR positive colorectal cancer (FDA.gov).

DrugClasses EGFR Antibody 27

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Therapy Description
NANT colorectal cancer vaccine combination
Cetuximab + JNJ 38877605
Cetuximab + Nivolumab
Cetuximab + Hu5F9-G4
Ficlatuzumab + Cetuximab
Cetuximab + Selumetinib + Vemurafenib
Binimetinib + Cetuximab + Encorafenib
Cisplatin + Docetaxel + Cetuximab
Cetuximab + Fluorouracil + NC-6004
Cetuximab + Cisplatin + Paclitaxel + Radiotherapy
Cetuximab + Prexasertib + Radiotherapy
Cetuximab + Sunitinib
LGK974 + LGX818 + Cetuximab
Cetuximab + Trastuzumab
Docetaxel + Cetuximab
REGN1400 + Cetuximab
Cetuximab + PLX4720
Cetuximab + Osimertinib
Cetuximab + FOLFIRI + Bevacizumab
ABBV-399 + Cetuximab
Vemurafenib + Cetuximab
Cetuximab Erbitux (cetuximab) is a monoclonal antibody directed against EGFR, which inhibits signal transduction and cell proliferation (PMID: 28695301). Erbitux (cetuximab) is FDA approved for use in head and neck squamous cell carcinoma and KRAS wild-type, EGFR positive colorectal cancer (FDA.gov).
Paclitaxel + Cetuximab
Cetuximab + Dabrafenib + Trametinib
AZD8055 + Cetuximab
Cetuximab + Durvalumab
BI 882370 + Cetuximab
Irinotecan + Oxaliplatin + Cetuximab
Cetuximab + Ipilimumab
Cetuximab + FOLFOX
Vemurafenib + Cetuximab + Irinotecan
NANT hepatocellular carcinoma vaccine combination
Carboplatin + Cetuximab + Cisplatin + Fluorouracil
Cetuximab + Pertuzumab
Cetuxmab + Sorafenib
Palbociclib + Cetuximab
Cetuximab + EAI045
Cetuximab + Imprime PGG
Cetuximab + Lenvatinib
Cetuximab + Dabrafenib + SCH772984
Carboplatin + Cetuximab + Paclitaxel
Cetuximab + ECF
Cetuximab + Luminespib
Cetuximab + C75
Irinotecan + Cetuximab + Ramucirumab
BYL719 + Cetuximab
Temsirolimus + Bevacizumab + Cetuximab
Temsirolimus + Cetuximab
Cetuximab + EGFR Antisense DNA
Afatinib + Cetuximab + Sirolimus
Cetuximab + Neratinib
Cetuximab + Selumetinib
Cetuximab + Trametinib
Afatinib + Cetuximab
Cetuximab + Urelumab
Cetuximab + SCH772984
Regorafenib + Cetuximab
Cetuximab + Carboplatin + Fluorouracil
Cetuximab + lenalidomide
Cetuximab + EGCG
Cyclophosphamide + Cetuximab
Cetuximab + IC
Pazopanib + Cetuximab
Cetuximab + Paclitaxel + Carboplatin + Erlotinib
Cetuximab + Lapatinib
Cetuximab + Cisplatin + Fluorouracil + Radiotherapy
Cetuximab + FOLFIRINOX
Cetuximab + Cisplatin + Vinorelbine
Cetuximab + FATE-NK100
Abraxane + Cisplatin + Cetuximab
Cetuximab + Cisplatin + Paclitaxel
Cetuximab + SP600125
Cetuximab + Ibrutinib
Cetuximab + Cisplatin
Cetuximab + Savolitinib
Cetuximab + Docetaxel + Methotrexate
Cetuximab + Fluorouracil + Irinotecan + Floxuridine
BKM120 + Cetuximab
Cetuximab + Motolimod
Cetuximab + Irinotecan + Utomilumab
Nilotinib + Cetuximab
NANT Chordoma Vaccine
Cetuximab + Cisplatin + Docetaxel + Fluorouracil
Cetuximab + Cisplatin + Patritumab
Avelumab + Cetuximab + Palbociclib
BGB-324 + Cetuximab
INC280 + Cetuximab
Cetuximab + Irinotecan
Abraxane + Carboplatin + Cetuximab
Cetuximab + Lumretuzumab
Temsirolimus + Bevacizumab + Valproic Acid + Cetuximab
Cetuximab + U0126
Cetuximab + CDX-3379
BGB-283 + Cetuximab
Cetuximab + Dasatinib + FOLFOX
Cetuximab + Mannitol
Cetuximab + Encorafenib
Olaparib + Cetuximab
Cetuximab + Methotrexate
Bevacizumab + Cetuximab + Irinotecan
Cetuximab + nab-paclitaxel
Cetuximab + IPH2201
Cabozantinib + Cetuximab
Cetuximab + Dabrafenib
Cetuximab + PEGPH20
Cetuximab + Dasatinib
Cetuximab + LSN3074753
Bevacizumab + Cetuximab
Pembrolizumab + Cetuximab
Cetuximab + Prexasertib
Fluorouracil + Cetuximab
Cetuximab + Napabucasin
LGX818 + Cetuximab + BYL719
Everolimus + Paclitaxel + Carboplatin + Cetuximab
Cetuximab + FOLFIRI
Cetuximab + EGFR Antisense DNA + Radiotherapy